|
|
||||||||
American Journal of Clinical Nutrition, Vol 68, 1104-1110, Copyright © 1998 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
A Bronstrup, M Hages, R Prinz-Langenohl and K Pietrzik
Institute of Nutritional Science, Department of Pathophysiology of Human Nutrition, University of Bonn, Germany.
BACKGROUND: Elevated plasma homocysteine concentrations are considered to be a risk factor for vascular disease and fetal malformations such as neural tube defects. Recent studies have shown that plasma homocysteine can be lowered by folic acid in amounts corresponding to 1- 2 times the recommended dietary allowance. Preliminary evidence indicates that vitamin B-12 may be beneficial when included in supplements or in a food-fortification regimen together with folic acid. OBJECTIVE: We aimed to compare the homocysteine-lowering potential of a folic acid supplement with that of 2 supplements containing different doses of vitamin B-12 in addition to folic acid. DESIGN: Female volunteers of childbearing age (n = 150) received a placebo for 4 wk followed by a 4-wk treatment with either 400 microg folic acid, 400 microg folic acid + 6 microg vitamin B-12, or 400 microg folic acid + 400 microg vitamin B-12. RESULTS: Significant reductions (P < 0.001) in plasma homocysteine were observed in all groups receiving vitamin treatment. The effect observed with the combination of folic acid + 400 microg vitamin B-12 (total homocysteine, -18%) was significantly larger than that with a supplement containing folic acid alone (total homocysteine, -11%) (P < 0.05). Folic acid in combination with a low vitamin B-12 dose (6 microg) affected homocysteine as well (-15%). CONCLUSIONS: These results suggest that the addition of vitamin B-12 to folic acid supplements or enriched foods maximizes the reduction of homocysteine and may thus increase the benefits of the proposed measures in the prevention of vascular disease and neural tube defects.
This article has been cited by other articles:
![]() |
A.T. Dobson, R.M. Davis, M.P. Rosen, S. Shen, P.F. Rinaudo, J. Chan, and M.I. Cedars Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF Hum. Reprod., February 1, 2007; 22(2): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Carrero, J. Fonolla, J. L. Marti, J. Jimenez, J. J. Boza, and E. Lopez-Huertas Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program J. Nutr., February 1, 2007; 137(2): 384 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Carrero, E. Lopez-Huertas, L. M. Salmeron, L. Baro, and E. Ros Daily Supplementation with (n-3) PUFAs, Oleic Acid, Folic Acid, and Vitamins B-6 and E Increases Pain-Free Walking Distance and Improves Risk Factors in Men with Peripheral Vascular Disease J. Nutr., June 1, 2005; 135(6): 1393 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Courtemanche, I. Elson-Schwab, S. T. Mashiyama, N. Kerry, and B. N. Ames Folate Deficiency Inhibits the Proliferation of Primary Human CD8+ T Lymphocytes In Vitro J. Immunol., September 1, 2004; 173(5): 3186 - 3192. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. McKay, J. M. Berkowitz, J. B. Blumberg, and J. P. Goldberg Communicating Cardiovascular Disease Risk Due to Elevated Homocysteine Levels: Using the EPPM to Develop Print Materials Health Educ Behav, June 1, 2004; 31(3): 355 - 371. [Abstract] [PDF] |
||||
![]() |
Y. Lamers, R. Prinz-Langenohl, R. Moser, and K. Pietrzik Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women Am. J. Clinical Nutrition, March 1, 2004; 79(3): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Bailey, G. C. Rampersaud, and G. P. A. Kauwell Folic Acid Supplements and Fortification Affect the Risk for Neural Tube Defects, Vascular Disease and Cancer: Evolving Science, J. Nutr., June 1, 2003; 133(6): 1961S - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Ronnenberg, M. B Goldman, D. Chen, I. W Aitken, W. C Willett, J. Selhub, and X. Xu Preconception homocysteine and B vitamin status and birth outcomes in Chinese women Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1385 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Choumenkovitch, J. Selhub, P. W. F. Wilson, J. I. Rader, I. H. Rosenberg, and P. F. Jacques Folic Acid Intake from Fortification in United States Exceeds Predictions J. Nutr., September 1, 2002; 132(9): 2792 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P Fohr, R. Prinz-Langenohl, A. Bronstrup, A. M Bohlmann, H. Nau, H. K Berthold, and K. Pietrzik 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women Am. J. Clinical Nutrition, February 1, 2002; 75(2): 275 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Silaste, M. Rantala, M. Sampi, G. Alfthan, A. Aro, and Y. A. Kesaniemi Polymorphisms of Key Enzymes in Homocysteine Metabolism Affect Diet Responsiveness of Plasma Homocysteine in Healthy Women J. Nutr., October 1, 2001; 131(10): 2643 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tice, E. Ross, P. G. Coxson, I. Rosenberg, M. C. Weinstein, M. G. M. Hunink, P. A. Goldman, L. Williams, and L. Goldman Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond JAMA, August 22, 2001; 286(8): 936 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Crott, S. T. Mashiyama, B. N. Ames, and M. F. Fenech Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro Carcinogenesis, July 1, 2001; 22(7): 1019 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Koehler, R. N Baumgartner, P. J Garry, R. H Allen, S. P Stabler, and E. B Rimm Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use Am. J. Clinical Nutrition, March 1, 2001; 73(3): 628 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. McKay, G. Perrone, H. Rasmussen, G. Dallal, and J. B. Blumberg Multivitamin/Mineral Supplementation Improves Plasma B-Vitamin Status and Homocysteine Concentration in Healthy Older Adults Consuming a Folate-Fortified Diet J. Nutr., December 1, 2000; 130(12): 3090 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Kurowska, J D. Spence, J. Jordan, S. Wetmore, D. J Freeman, L. A Piche, and P. Serratore HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1095 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. McKay, G. Perrone, H. Rasmussen, G. Dallal, W. Hartman, G. Cao, R. L. Prior, R. Roubenoff, and J. B. Blumberg The Effects of a Multivitamin/Mineral Supplement on Micronutrient Status, Antioxidant Capacity and Cytokine Production in Healthy Older Adults Consuming a Fortified Diet J. Am. Coll. Nutr., October 1, 2000; 19(5): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |